INTRODUCTION/AIM: Chronic viral hepatitis and its treatment with interferon (IFN) have an impact on patients' quality of life. The purpose of this study was to evaluate the degree of depression in patients with chronic viral hepatitis before and during IFN therapy. PATIENTS/ METHODS: Our study group comprised 132 patients, 38 with chronic hepatitis C (26 males, 12 females), 36 with chronic hepatitis B (29 males, 7 females), and 58 individuals with no chronic disease (24 males, 34 females). Depression was assessed using the Zung Self-Rating Depression Scale and the corresponding SDS index. RESULTS: At baseline, patients with viral hepatitis and healthy controls had similar SDS indexes. During treatment, a significant increase in the SDS index was observed in both HBV and HCV patients (p < 0.001), which returned to the baseline levels after treatment. During IFN therapy, the SDS indexes were higher in HCV compared to HBV patients and women compared to men (p = 0.001 and p = 0.008, respectively), and there was a >5- fold increased frequency to develop severe depression. CONCLUSIONS: IFN-induced depression occurs more frequently in HCV than HBV patients and in women than men. Monitoring during treatment is mandatory in order to maximize treatment adherence. Copyright 2002 S. Karger AG, Basel
INTRODUCTION/AIM: Chronic viral hepatitis and its treatment with interferon (IFN) have an impact on patients' quality of life. The purpose of this study was to evaluate the degree of depression in patients with chronic viral hepatitis before and during IFN therapy. PATIENTS/ METHODS: Our study group comprised 132 patients, 38 with chronic hepatitis C (26 males, 12 females), 36 with chronic hepatitis B (29 males, 7 females), and 58 individuals with no chronic disease (24 males, 34 females). Depression was assessed using the Zung Self-Rating Depression Scale and the corresponding SDS index. RESULTS: At baseline, patients with viral hepatitis and healthy controls had similar SDS indexes. During treatment, a significant increase in the SDS index was observed in both HBV and HCV patients (p < 0.001), which returned to the baseline levels after treatment. During IFN therapy, the SDS indexes were higher in HCV compared to HBV patients and women compared to men (p = 0.001 and p = 0.008, respectively), and there was a >5- fold increased frequency to develop severe depression. CONCLUSIONS:IFN-induced depression occurs more frequently in HCV than HBV patients and in women than men. Monitoring during treatment is mandatory in order to maximize treatment adherence. Copyright 2002 S. Karger AG, Basel
Authors: Debika Bhattacharya; T Umbleja; F Carrat; R T Chung; M G Peters; F Torriani; J Andersen; J S Currier Journal: J Acquir Immune Defic Syndr Date: 2010-10 Impact factor: 3.731
Authors: E Sinakos; E Gigi; T Lalla; A-L Bellou; A Sykja; E Orphanou; E Vrettou; V Tsapas; M Raptopoulou Journal: Hippokratia Date: 2010-04 Impact factor: 0.471
Authors: Charles L Raison; Andrey S Borisov; Sherry D Broadwell; Lucile Capuron; Bobbi J Woolwine; Ira M Jacobson; Charles B Nemeroff; Andrew H Miller Journal: J Clin Psychiatry Date: 2005-01 Impact factor: 4.384
Authors: Mona Moieni; Michael R Irwin; Ivana Jevtic; Richard Olmstead; Elizabeth C Breen; Naomi I Eisenberger Journal: Neuropsychopharmacology Date: 2015-01-19 Impact factor: 7.853